Diabetes Mellitus, Non-Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.
|
29632382 |
2018 |
Pancreatic carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Moreover, Ets-1 mRNA and protein were constitutively expressed together with Pim-3 in human pancreatic cancer cell lines.
|
19154409 |
2009 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
|
24789328 |
2014 |
Pancreatic carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Pim-3 expression was a prognostic indicator related to poor survival in pancreatic cancer patients.
|
25971209 |
2015 |
Pancreatic carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The growth inhibitory effects of T26 were reversed by overexpression of Pim-3 cDNA in human pancreatic cancer cells, indicating that T26 acts primarily on Pim-3.
|
21981263 |
2012 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Moreover, TCTP colocalized with Pim-3 both in human pancreatic cancer cells and in clinical tissues.
|
24165482 |
2013 |
Pancreatic carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
|
16818649 |
2006 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The PIM-3 kinase was the PIM family member most often associated with PC oncogenesis and was also the kinase inhibited the most by Ter among more than 600 kinases investigated.
|
31211245 |
2019 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Targeting Pim-3 may be a promising way to improve treatment efficacy in combination with radiotherapy in human pancreatic cancer.
|
27016481 |
2016 |
Pancreatic carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
There are reports indicating that overexpression of PIM3 is associated with the promotion of pancreatic cancer cell proliferation.
|
26238203 |
2015 |
Pancreatic carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We constructed retroviral vectors for human Pim-3 and a kinase-dead mutant of human Pim-3 (K69M); the retroviral supernatants generated from these vectors were then used to infect the human pancreatic cancer cell line MiaPaCa-2 to establish stable cell lines.
|
23845873 |
2013 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Herein we investigated the involvement of proto-oncogene Pim-3 in driving the stemness properties in pancreatic cancer.
|
28775772 |
2017 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pim-3 could promote growth and angiogenesis of human pancreatic cancer cells in vivo in an orthotopic nude mouse model.
|
25071334 |
2014 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results suggest combining drug therapies that inhibit Pim kinases, such as Pim-3, with chemotherapeutic agents, to aid in decreasing chemoresistance in pancreatic cancer.
|
23760491 |
2013 |
Malignant neoplasm of pancreas
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Pim-3 expression was a prognostic indicator related to poor survival in pancreatic cancer patients.
|
25971209 |
2015 |
Malignant neoplasm of pancreas
|
0.100 |
Biomarker
|
disease |
BEFREE |
Moreover, TCTP colocalized with Pim-3 both in human pancreatic cancer cells and in clinical tissues.
|
24165482 |
2013 |
Malignant neoplasm of pancreas
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Moreover, Ets-1 mRNA and protein were constitutively expressed together with Pim-3 in human pancreatic cancer cell lines.
|
19154409 |
2009 |
Malignant neoplasm of pancreas
|
0.100 |
Biomarker
|
disease |
BEFREE |
Herein we investigated the involvement of proto-oncogene Pim-3 in driving the stemness properties in pancreatic cancer.
|
28775772 |
2017 |
Malignant neoplasm of pancreas
|
0.100 |
Biomarker
|
disease |
BEFREE |
Targeting Pim-3 may be a promising way to improve treatment efficacy in combination with radiotherapy in human pancreatic cancer.
|
27016481 |
2016 |
Malignant neoplasm of pancreas
|
0.100 |
Biomarker
|
disease |
BEFREE |
The PIM-3 kinase was the PIM family member most often associated with PC oncogenesis and was also the kinase inhibited the most by Ter among more than 600 kinases investigated.
|
31211245 |
2019 |
Malignant neoplasm of pancreas
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results suggest combining drug therapies that inhibit Pim kinases, such as Pim-3, with chemotherapeutic agents, to aid in decreasing chemoresistance in pancreatic cancer.
|
23760491 |
2013 |
Malignant neoplasm of pancreas
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
|
24789328 |
2014 |
Malignant neoplasm of pancreas
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pim-3 could promote growth and angiogenesis of human pancreatic cancer cells in vivo in an orthotopic nude mouse model.
|
25071334 |
2014 |
Malignant neoplasm of pancreas
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
|
16818649 |
2006 |
Malignant neoplasm of pancreas
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We constructed retroviral vectors for human Pim-3 and a kinase-dead mutant of human Pim-3 (K69M); the retroviral supernatants generated from these vectors were then used to infect the human pancreatic cancer cell line MiaPaCa-2 to establish stable cell lines.
|
23845873 |
2013 |